SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-005442
Filing Date
2020-05-14
Accepted
2020-05-14 13:08:11
Documents
5
Period of Report
2020-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT biei_8k.htm 8-K 32462
2 TECHNOLOGY ACQUISITION AND FINANCING AGREEMENT DATED MAY 8, 2020 biei_ex101.htm EX-10.1 50946
3 INTELLECTUAL PROPERTY AGREEMENT DATED MAY 12, 2020 biei_ex102.htm EX-10.2 70461
4 THIRD ADDENDUM TO LICENSE AGREEMENT WITH MARV ENTERPRISES, LLC DATED MAY 11, 202 biei_ex103.htm EX-10.3 12166
5 IMAGE prem.jpg GRAPHIC 2305
  Complete submission text file 0001654954-20-005442.txt   170439
Mailing Address P.O. BOX 25 JACKSON CENTER PA 16133
Business Address P.O. BOX 25 JACKSON CENTER PA 16133 724-633-7033
PREMIER BIOMEDICAL INC (Filer) CIK: 0001515740 (see all company filings)

IRS No.: 272635666 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54563 | Film No.: 20876655
SIC: 2836 Biological Products, (No Diagnostic Substances)